Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation

OBJECTIVE: This study aimed to evaluate the efficacy and safety of eltrombopag (ELT) in the treatment of thrombocytopenia following hematopoietic stem cell transplantation (HSCT). MATERIALS AND METHODS: Forty-eight patients treated with ELT for thrombocytopenia after allogeneic or autologous transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Güven, Zeynep Tuğba, Çelik, Serhat, Eser, Bülent, Çetin, Mustafa, Ünal, Ali, Kaynar, Leylagül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160700/
https://www.ncbi.nlm.nih.gov/pubmed/35297243
http://dx.doi.org/10.4274/tjh.galenos.2022.2021.0675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160700/
https://www.ncbi.nlm.nih.gov/pubmed/35297243
http://dx.doi.org/10.4274/tjh.galenos.2022.2021.0675

Ejemplares similares